ArticleBMC immunology2026
G protein-coupled receptor autoantibody expression patterns in adults with decelerated biological aging mirror pediatric profiles.
Article in BMC immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundG protein-coupled receptors (GPCRs) represent the largest and most diverse family of membrane proteins. In addition to their endogenous ligands, functional natural autoantibodies (Aab) have also been shown to bind and modulate GPCRs. Aab concentration is known to increase with chronological age, and several studies demonstrated an association of certain GPCR-binding Aab with chronic inflammation, concretely with specific autoimmune diseases in adults. However, prevalence of GPCR-Aab in pediatric population is not known so far.
methodsIn this descriptive study, we investigated the levels of Aab targeting 14 distinct GPCRs across individuals (pediatric, n = 83, adults n = 198) taking into consideration chronological and biological age, as defined by PhenoAge clock.
resultsOur findings suggest, that anti-GPCR Aab are present from childhood through adulthood; however, their expression patterns undergo significant changes over the course of life. Specifically, we observed a significant increase in Aab targeting ACE2, CXCR3, and BDKRB1 in adults and older individuals. Conversely, concentrations of Aab against ATR1, ADRA1A, ADRB2, and ETAR were significantly higher in children compared to adults. We also assessed the impact of age acceleration on Aab levels, defined by a positive Δ age score based on the PhenoAge clock. Distinct GPCR Aab expression signatures correlated with accelerated aging, differing notably from patterns seen in pediatric and adult cohorts. Concretely, the expression profile of GPCR Aab in -Δage adults exhibits similarity to that observed in the pediatric cohort. Furthermore, we found a concordant presence of CXCR3-Aab and expansion of CXCR3 + T cells with increased chronological age.
conclusionsBecause systemic chronic inflammation is a known driver of accelerated aging, we hypothesize that the altered Aab expression profiles observed in biologically older adults may reflect this underlying inflammatory state. Although future research will be essential to evaluate the therapeutic potential of targeting these GPCRs in the context of inflammaging and autoimmune pathophysiology, chronological as well as biological age should be considered when assessing GPCR-Aab patterns.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.